Stocks are looking to rebound from a weak start to the week, but futures are down in the premarket.... January 17, 2024 | [Read Online]( Chris Dinello
January 17, 2024 Good Morning! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Welcome back from a long holiday weekend. Now, let's get ready to trade! Markets ð The market turned in a weak performance in its first day back from the long weekend. Large-cap indexes edged lower, and the small-cap Russ 2K sold off. - S&P 500 [-0.3%] - Dow [-0.6%] - Nasdaq [-0.1%] - Russell 2K [-1.1%] S&P 500 and Dow futures are both down 0.3% in early premarket trading. [Regime Change At Federal Reserve?]( The Fed just began the rollout of a new technology that'll "shake the US financial system". It'll likely go down in history as the biggest change to the financial system since Western Unionâs "lightning lines." [Take These 3 Steps Now to Maximize This Opportunity]( Premarket Highlights ð ð Chinese Stocks Touch News Lows Chinese markets experienced significant sell-offs on Wednesday, triggered by a series of discouraging economic reports. The data painted a grim picture of the country's current economic state, leading to widespread selling of Chinese stocks. The benchmark CSI 300 index fell 2.2%, reaching a near five-year low. Hong Kong's Hang Seng Index suffered a 3.7% drop, its lowest close in about 15 months. This marks a substantial loss since its peak in February 2021. ð Economic ChallengesÂ
Chinaâs economy grew by 5.2% last year, marginally surpassing the government's targets. However, this silver lining is overshadowed by multiple economic hurdles. The country is grappling with various challenges, such as deflation, weakening export demand, and a prolonged downturn in the real estate sector. This overall market response reflects investor concerns about China's economic health and future prospects, amidst internal and external economic pressures. What to Watch Today ð Retail Sales
The final retail sales report for 2023 will drop ahead of todayâs open, and it will tell investors how retailers fared during the crucial holiday season. Holiday spending provides a valuable metric for inferring consumersâ confidence in the economy and their financial health. Featured Earnings ð² - Prologis [PLD] ... AM - Charles Schwab [SCHW] ...AM - U.S. Bancorp [USB] ... AM - Citizens Financial Group [CFG] ... AM - Kinder Morgan [KMI] ... PM - Discover Financial [DFS] ... PM - Wintrust Financial [WTFC] ... PM - Synovus Financial [SNV] ... PM - Alcoa [AA] ... PM - H. B. Fuller [FUL] ... PM Economy ð - Import price index [Dec] ... 8:30a - U.S. retail sales [Dec] ... 8:30a - Industrial production [Dec] ... 9:15a - Business inventories [Nov] ... 9:15a - Home builder confidence index [Jan] ... 10:00a Running Hot ð¥ Gainers - Chicken Soup for the Soul [CSSEL] >> +45.1% - Meta Materials [MMAT] >> +17.7% - Riskon Intl. [ROI] >> +12.6% Decliners - Phunware [PHUN] >> (60.8%) - Tusimple Holdings [TSP] >> (41.5%) - DatChat [DATS] >> (37.1%) BullFrog AI [BFRG] - Last Close: $2.64 In an early morning press release, the AI company said its collaboration with the Lieber Institute for Brain Development may have produced a breakthrough. BullFrog said early findings from the partnership have successfully stratified brain expression data, which could provide insights into psychiatric conditions. The study clustered subjects based solely on their biological data, independent of their behavioral diagnoses. The approach highlights differences and similarities in biological pathways across various brain disorders. BFRG is up 23.1% on more than 3 million shares traded. My Take: BFRG is coming off a pullback, but this catalyst could help it regain its form. ZyVersa Therapeutics [ZVSA] - Last Close: $0.6925 This tiny biotech is getting a boost after publishing an article in the peer-reviewed publication Acta Neuropathologica Communications. The company said the article demonstrates âinflammasome activation enhances cancer metastasis to the brain in women with TNBC.â ZVSA is up 80.5% on the news, with more than 3.5 million shares changing hands in the premarket. My Take: ZVSA has struggled as of late, but this rally could put it back on track. Shares could find support at the $1 mark. INVO Bioscience [INVO] - Last Close: $1.05 This tiny biotech filed new disclosures in the lead up to its proposed merger with NAYA Biosciences early this morning. INVO Bio will hold a shareholder vote to approve the merger soon, and itâs also facilitating a public offering. After Tuesdayâs close, the company published a Form S-4 filing detailing its plans for the offering and the agenda for the upcoming shareholder meeting. INVO is up 16.5% in the premarket on thin trading volume. My Take: INVOâs modest mover higher doesnât have a lot of volume to support it. I think this rally could materialize quickly once its momentum begins to fade. Airspan Networks [MIMO] - Last Close: $0.0769 This morning, this IT firm announced a new partnership with GCT Semiconductor to develop a âstate-of-the-artâ RF module. Airspan said the RF module will be designed for use in various devices, and the company is building out a scalable virtual core network to support the systems. It also announced the launch of a new family of vRAN radios covering the sub 1Ghz spectrum. MIMO is todayâs top premarket stock with a 242.0% gain on 38 million shares traded. My Take: MIMO has an extremely small float, so this stock could experience significant volatility in todayâs session. That's it for today! Thanks for reading, and good luck out there! Best Regards, â Chris D.
Elite Trade Club Text ELITE to 47121 or [click here](Â to get our alerts on your mobile device, and never miss another fast-moving stock! P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP. [Sign up for SMS]( Join Elite Growth Stocks for instant access to this report. [Get Instant Access Now]( [tw]( [ig]( [yt]( [tk]( *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails. [Privacy Policy]( | [Terms of Service]( Update your email preferences or unsubscribe [here]( © 2024 Elite Trade Media LLC 1969 Alafaya Tr., Suite #247
Orlando, Florida 32828, United States of America